Labeling Claims for Colostrum Products Make Them Unapproved Drugs

Drug Industry Daily
A A
The FDA cited multiple problems with labeling claims at a Phoenix manufacturer that specializes in colostrum, the milk produced by maternal mammals immediately after giving birth.

To View This Article:

Login

Subscribe To Drug Industry Daily